Application of artificial neural network modelling to identify severely ill patients whose aminoglycoside concentrations are likely to fall below therapeutic concentrations. [electronic resource]
- Journal of clinical pharmacy and therapeutics Oct 2003
- 425-32 p. digital
Publication Type: Journal Article
0269-4727
10.1046/j.0269-4727.2003.00514.x doi
Amikacin--therapeutic use Aminoglycosides--blood Anti-Bacterial Agents--therapeutic use Artificial Intelligence Dibekacin--analogs & derivatives Humans Intensive Care Units Logistic Models Neural Networks, Computer Predictive Value of Tests Reference Values Severity of Illness Index